Editors' ChoiceCancer

Prostate cancer loses when androgen receptor can’t stick the landing

See allHide authors and affiliations

Science Translational Medicine  16 Aug 2017:
Vol. 9, Issue 403, eaao4208
DOI: 10.1126/scitranslmed.aao4208


A small-molecule inhibitor blocks the interaction of the androgen receptor with DNA to target drug-resistant prostate cancer.

View Full Text